BILL NUMBER: S10711
SPONSOR: SCARCELLA-SPANTON
 
TITLE OF BILL:
An act to amend the public health law, in relation to requiring certain
physicians or other authorized practitioners to offer prenatal testing
for antiphospholipid syndrome
 
PURPOSE OR GENERAL IDEA OF BILL:
This bill would require certain medical practitioners to offer prenatal,
antiphospholipid syndrome testing
 
SUMMARY OF PROVISIONS:
Section 1 amends the public health law by adding new section 2533.
Subdivision 1 of section 2533 of the public health law states that
physicians or other authorized practitioners must offer prenatal blood
testing for antiphospholipid syndrome. Subdivision 2 of section 2533 of
the public health law directs the commissioner to create any regulations
necessary to ensure these new requirements.
Section 2 is the effective date.
 
JUSTIFICATION:
Antiphospholipid syndrome (APS), sometimes referred to as "sticky
blood," is an autoimmune disorder that makes the blood prone to danger-
ous clots. If undiagnosed, this can be especially dangerous during preg-
nancy as clotted blood prevents adequate blood flow to the placenta,
which could result in miscarriage. The risk of miscarriage can be
dramatically lowered if diagnosed and treated with blood thinning medi-
cation; however, the majority of women with APS are not treated until
they have had multiple miscarriages. By mandating that prenatal APS
testing is offered, there is potential to drastically reduce recurring
pregnancy loss.
 
PRIOR LEGISLATIVE HISTORY:
New
 
FISCAL IMPLICATIONS:
To be determined.
 
EFFECTIVE DATE:
This act shall take effect on the ninetieth day after it shall have
become a law.